Home › Seizures › Pennsylvania
Seizures clinical trials in Pennsylvania
12 studies for Seizures are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Thomas Jefferson University, Philadelphia
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07563881A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- The Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 3
Ages 2 and older · All sexes · Updated Sep 15, 2026 · NCT04462770An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 3
Ages 2 to 55 · All sexes · Updated Sep 15, 2026 · NCT05066217Prospective Natural History Study of POLG Disease
- Children's Hospital of Philadelphia-Philadelphia, Philadelphia
RecruitingObservational study
All ages · All sexes · Updated Sep 15, 2026 · NCT07775872A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
- UPMC, Pittsburgh
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Aug 24, 2026 · NCT06132893A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Praxis Research Site, Philadelphia
RecruitingPhase 3
1 Day – 18 Years · All sexes · Updated Aug 3, 2026 · NCT07019922Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children
- Children's Hospital of Philadelphia, Philadelphia
RecruitingObservational study
1 Month – 18 Years · All sexes · Updated Jun 29, 2026 · NCT03419260Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Thomas Jefferson University Hospital, Philadelphia
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jun 9, 2026 · NCT05135091A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
- University of Pennsylvania - Department of Neurology, Philadelphia
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jan 23, 2026 · NCT07219407Pediatric Dose Optimization for Seizures in Emergency Medical Services
- University of Pittsburgh, Pittsburgh
RecruitingPhase 3
6 Months – 13 Years · All sexes · Updated Sep 30, 2025 · NCT05121324Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 3
Ages 4 to 55 · All sexes · Updated Jul 24, 2025 · NCT05219617Epilepsy Learning Healthcare System (ELHS)
- Penn State Hershey, Hershey
- Children's Hospital of Philadelphia (CHOP), Philadelphia
RecruitingObservational study
All ages · All sexes · Updated Aug 30, 2024 · NCT06265103From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.